According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients who received only an immune-based treatment to help their own immune ...

Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...

Pilot study finds rectal cancer surgery shifts the perioperative microbiome, lowering diversity and increasing Enterococcus ...

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the re ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor. Subscribe to our ...